Report from the first Tanzania Liver Cancer Conference: a call for action to unite in the fight against liver cancer in Sub-Saharan Africa, 17-18 March 2023, Dar es Salaam, Tanzania.

Autor: Mwanga A; Department of Surgery, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.; Dr Mwanga and Dr Mbuguje contributed equally and are designated co-first authors on this manuscript., Mbuguje E; Department of Radiology and Imaging, Muhimbili National Hospital, Dar es Salaam, Tanzania.; Dr Mwanga and Dr Mbuguje contributed equally and are designated co-first authors on this manuscript., Alswang J; Harvard Medical School, Boston, MA 02115, USA., Brand N; Department of Surgery, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.; Department of Surgery, University of California, San Francisco, CA 94143, USA., Swallow A; Department of Surgery, Muhimbili National Hospital, Dar es Salaam, Tanzania., Mwanakulya DB; Department of Internal Medicine, Adult Oncology Unit, Muhimbili National Hospital, Dar es Salaam, Tanzania., Pallangyo C; Clinical Research, Training and Consultancy Unit, Muhimbili National Hospital, Dar es Salaam, Tanzania., Wibonela S; Department of Surgery, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania., Uiso E; Department of Internal Medicine, Medical Gastroenterology Unit, Muhimbili National Hospital, Dar es Salaam, Tanzania., Kitua W; Department of Surgery, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania., Pazi S; Department of Internal Medicine, Medical Gastroenterology Unit, Muhimbili National Hospital, Dar es Salaam, Tanzania.
Jazyk: angličtina
Zdroj: Ecancermedicalscience [Ecancermedicalscience] 2023 May 02; Vol. 17, pp. 1543. Date of Electronic Publication: 2023 May 02 (Print Publication: 2023).
DOI: 10.3332/ecancer.2023.1543
Abstrakt: The first Tanzania Liver Cancer Conference (TLCC2023) took place on 17-18 March 2023 in Dar es Salaam, Tanzania with the aim of raising awareness among healthcare providers on the problem that liver cancer poses to the Tanzanian population and the urgent need to address this important issue. The conference focused on the following agenda items: 1) to build awareness among local healthcare providers on the status of liver cancer in Tanzania and the available diagnostic and management options, 2) to update Tanzanian healthcare providers on the current standard of care for liver cancer provided in developed countries and recent advancements in liver cancer care and 3) to promote an inclusive and multidisciplinary approach in research and the clinical care of patients with liver cancer in Tanzania. TLCC2023 was preceded by community-facing pre-conference activities, including screening 684 community members for hepatitis B virus free of charge. The conference was attended by 161 healthcare professionals from varying disciplines across Tanzania and abroad. TLCC2023 featured over 30 speakers from Tanzania, Kenya, Egypt, India and the United States that comprehensively covered a wide range of topics related to research and clinical care of liver cancer patients. A holistic and unified approach integrating both private and public sectors is vital in improving care for patients with liver cancer, and this was a common theme ingrained in the majority of presentations. Overall, the conference was well-received by attendees and knowledge assessment scores improved from 50% pre-conference to 75% post-conference (p < 0.001), demonstrating its educational value. As Tanzania's first conference on the subject, TLCC2023 marked an important milestone in a united fight against liver cancer in the country and beyond.
Competing Interests: No authors of this manuscript report any conflict of interest.
(© the authors; licensee ecancermedicalscience.)
Databáze: MEDLINE
Externí odkaz: